Despite making up over half of the workforce in the pharmaceutical industry, women hold only about 25% of executive-level positions. In the lead-up to International ...

The IPI team spoke to Shivaji Jadhav from Aragen, an India-headquartered CDMO that recently received a Platinum rating from EcoVadis, placing it among the top 1% of ...

PCI recently announced the acquisition of Ajinomoto Althea. How does this acquisition enhance PCI’s sterile fill-finish capabilities and strategy?  The acqui...

Pharma companies remain at differing levels of readiness for implementing ISO IDMP product data standards, and in their maturity around adopting FAIR data principles...

Since the United Kingdom’s exit from the European Union in 2020, there have been numerous changes in the procedures implemented to ensure that there is access to med...

Pharmacovigilance is by its nature a detail-driven undertaking, and within it monitoring medical literature for safety signals is notoriously labour-intensive. Nowhe...

A key challenge in developing therapeutic vaccines against cancer is getting the correct vaccine target delivered to the correct immune cells in the correct cellular...

The drug delivery device industry faces a number of significant challenges with regard to sustainability, from reliance on single-use plastics to resource-intensive ...

As injectable drugs continue to expand across therapeutic areas, designing patient-centric clinical trials is critical for success. This article explores the interse...

Digital health technologies are revolutionising clinical trial operations – transforming how studies are designed, conducted, and experienced by patients. From impro...